Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous v3.5.3. This indicates a newer build/version of the page rather than content changes.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s footer revision label has been updated from “v3.5.2” to “v3.5.3,” reflecting an underlying system/version change without changing the displayed study details.SummaryDifference0.0%

- Check38 days agoChange DetectedEnglish-language location labels were added for Hradec Králové Region, Moravian-Silesian Region, Olomouc Region, and Bucharest with corresponding city+region entries, replacing the previous local-language region labels. The revision version was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check53 days agoChange DetectedLocation name updated from Padua to Padova, Italy, 35128. The old Padua listing was removed and the Padova listing added to reflect the local city name.SummaryDifference0.0%

- Check67 days agoChange DetectedExpanded list of study locations with numerous new sites across multiple countries (Spain, Romania, Italy, France, Portugal, Mexico, Brazil, Czechia, Poland, Belgium, Austria, the United States, and more). Several existing sites changed status (Not yet recruiting, Completed) or were withdrawn/removed.SummaryDifference3%

- Check81 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a release note and does not alter the study details.SummaryDifference0.0%

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.